BUY Titan Company Ltd. — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Intraday)11 Aug 2026, 9:07 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Titan's Q1 dials up street optimism
NewsEt-Markets·11 Aug · today
Titan shares: Is the Tata Group stock an attractive buy after Q1FY27 results?
NewsLivemint·10 Aug · yesterday
Titan surges 2.78%, SBI drags; Nifty clings to gains amid geopolitical jitters
NewsHbl·10 Aug · yesterday
Titan's Diamond Jewellery Growth Catches Up With Gold For First Time In Quarters: CFO
NewsNdtv-Profit·10 Aug · yesterday
Titan hits 52-week high as Q1 results trigger analyst upgrades
NewsHbl·10 Aug · yesterday
Titan To Hindalco Q1 Review: Buy, Add Or Hold? Here's ICICI Securities' Take
NewsNdtv-Profit·10 Aug · yesterday
Titan Company Limited has submitted to the Exchange, Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026.
NSE · Outcome of Board Meeting·7 Aug · 3d ago
Titan Q1 Results Today: Time, Earnings Call, Dividend, What To Watch, Share Price
NewsNdtv-Profit·7 Aug · 4d ago
CARE Ratings has reaffirmed the ratings for Titan Company Ltd's commercial paper, long-term/short-term bank facilities, and short-term bank facilities. The ratings are CARE A1+ for commercial paper, C
BSE · Company Update·4 Aug · 1w ago
1 advisor has an active swing SELL call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·30 Jul · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Titan Company
- BUY — Sumeet Bagadia, Choice Broking20 Oct 2026 · ~3 months · target ₹4,860 · Active
- BUY — Rakesh Bansal19 Oct 2026 · Same day · target ₹4,580 · SL hit
- BUY — Mehul Kothari, Anand Rathi19 Oct 2026 · Same day · target ₹4,600 · SL hit
- BUY — Vaishali Parekh, Prabhudas Lilladher19 Oct 2026 · ~2 weeks · target ₹4,650 · SL hit
- BUY — Rachna Vaidya8 Oct 2026 · ~2 weeks · target ₹4,460 · Target hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

